What is the address of Dr. INDESTEEGE -DR.HORVATH?

The registered office of Dr. INDESTEEGE -DR.HORVATH is located at Peerboomstraat 23, 3600 Genk.

Is Dr. INDESTEEGE -DR.HORVATH still active?

Yes. According to the CBE (29 September 2026) Dr. INDESTEEGE -DR.HORVATH is active, legal situation “Normale toestand”, started on 29 November 1994.

Is Dr. INDESTEEGE -DR.HORVATH registered on Peppol?

Yes, Dr. INDESTEEGE -DR.HORVATH is registered on the Peppol network with ID 0208:0453929910.

What is the enterprise number of Dr. INDESTEEGE -DR.HORVATH?

The enterprise number of Dr. INDESTEEGE -DR.HORVATH is BE0453929910.

When was Dr. INDESTEEGE -DR.HORVATH founded?

Dr. INDESTEEGE -DR.HORVATH was founded on 29 November 1994.

Who are the directors of Dr. INDESTEEGE -DR.HORVATH?

According to the 2025 annual accounts, the directors of Dr. INDESTEEGE -DR.HORVATH are: Monique Horvath, Frans Indesteege.

Is Dr. INDESTEEGE -DR.HORVATH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 1994; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. INDESTEEGE -DR.HORVATH make in 2025?

Dr. INDESTEEGE -DR.HORVATH posted a profit after taxes of € 292,569 in financial year 2025.

What is the revenue of Dr. INDESTEEGE -DR.HORVATH?

As a small company, Dr. INDESTEEGE -DR.HORVATH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 399,461.

Dr. INDESTEEGE -DR.HORVATH (Private Limited) - Genk

Dossier Dr. INDESTEEGE -DR.HORVATH, printed on 29 September 2026 from databakkes.be/en/0453929910/dr-indesteege-dr-horvath. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. INDESTEEGE -DR.HORVATH from Genk, company number BE0453929910, closed financial year 2025 with a result of € 292,569 after tax. For that financial year Dr. INDESTEEGE -DR.HORVATH recorded a gross margin of € 399,461 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 222,739 to € 292,569. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 1.4 million

▲ 27% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 292,569

▲ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 192,964

▲ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.4 million.

People and assets in 2025

Vehicles and equipment

€ 69,866

▲ € 66,335 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,954

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 38,163

▲ 166% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 362,598 Gross margin 2022: € 362,598 First fiscal year in the series	€ 370,737 Gross margin 2023: € 370,737 ▲ 2% vs 2022 (€ 362,598) Favourable step	€ 350,074 Gross margin 2024: € 350,074 ▼ 6% vs 2023 (€ 370,737) Unfavourable step	€ 399,461 Gross margin 2025: € 399,461 ▲ 14% vs 2024 (€ 350,074) Favourable step	▲ 14%
Profit after taxes	€ 223,817 Profit after taxes 2022: € 223,817 First fiscal year in the series	€ 232,417 Profit after taxes 2023: € 232,417 ▲ 4% vs 2022 (€ 223,817) Favourable step	€ 222,739 Profit after taxes 2024: € 222,739 ▼ 4% vs 2023 (€ 232,417) Unfavourable step	€ 292,569 Profit after taxes 2025: € 292,569 ▲ 31% vs 2024 (€ 222,739) Favourable step	▲ 31%
Equity	€ 1,366,884 Equity 2022: € 1,366,884 First fiscal year in the series	€ 1,344,557 Equity 2023: € 1,344,557 ▼ 2% vs 2022 (€ 1,366,884) Unfavourable step	€ 1,102,697 Equity 2024: € 1,102,697 ▼ 18% vs 2023 (€ 1,344,557) Unfavourable step	€ 1,395,266 Equity 2025: € 1,395,266 ▲ 27% vs 2024 (€ 1,102,697) Favourable step	▲ 27%
Total debts	€ 75,200 Total debts 2022: € 75,200 First fiscal year in the series	€ 268,400 Total debts 2023: € 268,400 ▲ 257% vs 2022 (€ 75,200) Unfavourable step	€ 530,564 Total debts 2024: € 530,564 ▲ 98% vs 2023 (€ 268,400) Unfavourable step	€ 170,993 Total debts 2025: € 170,993 ▼ 68% vs 2024 (€ 530,564) Favourable step	▼ 68%
Cash	€ 222,845 Cash 2022: € 222,845 First fiscal year in the series	€ 124,482 Cash 2023: € 124,482 ▼ 44% vs 2022 (€ 222,845) Unfavourable step	€ 109,906 Cash 2024: € 109,906 ▼ 12% vs 2023 (€ 124,482) Unfavourable step	€ 192,964 Cash 2025: € 192,964 ▲ 76% vs 2024 (€ 109,906) Favourable step	▲ 76%
Retained profit	€ 1,358,528 Retained profit 2022: € 1,358,528 First fiscal year in the series	€ 1,336,202 Retained profit 2023: € 1,336,202 ▼ 2% vs 2022 (€ 1,358,528) Unfavourable step	€ 1,094,342 Retained profit 2024: € 1,094,342 ▼ 18% vs 2023 (€ 1,336,202) Unfavourable step	€ 1,386,911 Retained profit 2025: € 1,386,911 ▲ 27% vs 2024 (€ 1,094,342) Favourable step	▲ 27%
Dividend	€ 237,535 Dividend 2022: € 237,535 First fiscal year in the series	€ 254,743 Dividend 2023: € 254,743 ▲ 7% vs 2022 (€ 237,535) Unchanged	€ 464,599 Dividend 2024: € 464,599 ▲ 82% vs 2023 (€ 254,743) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 464,599) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 38,376 Bank debt 2024: € 38,376 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 38,376) Favourable step	▼ 100%
Balance sheet total	€ 1,442,084 Balance sheet total 2022: € 1,442,084 First fiscal year in the series	€ 1,612,958 Balance sheet total 2023: € 1,612,958 ▲ 12% vs 2022 (€ 1,442,084) Unchanged	€ 1,633,261 Balance sheet total 2024: € 1,633,261 ▲ 1% vs 2023 (€ 1,612,958) Unchanged	€ 1,566,259 Balance sheet total 2025: € 1,566,259 ▼ 4% vs 2024 (€ 1,633,261) Unchanged	▼ 4%

Key figures of Dr. INDESTEEGE -DR.HORVATH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. INDESTEEGE -DR.HORVATH?

What happened at Dr. INDESTEEGE -DR.HORVATH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 292,569 (▲ 31% vs 2024). Source: NBB ↗
2022 Monique Horvath became a director. NBB
2022 Frans Indesteege became a director. NBB
Sep 30, 1995 New establishment in Genk. KBO
Nov 29, 1994 Start of the company according to the CBE. KBO

In short

From € 223,817 profit in 2022 to € 292,569 profit in 2025.

Paid € 465,313 in corporate taxes since 2022.

Best year ever: 2025, with € 292,569 profit.

Paid out € 956,877 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. INDESTEEGE -DR.HORVATH? We notify you, reason included.

Follow Dr. INDESTEEGE -DR.HORVATH

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Monique Horvath Frans Indesteege

Dr. INDESTEEGE -DR.HORVATH

Behind Dr. INDESTEEGE -DR.HORVATH are Monique Horvath and Frans Indesteege.

See the full network in the app

Directors

According to the 2025 annual accounts

Monique Horvath

Director

since 2022

Frans Indesteege

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Peerboomstraat 23

3600 Genk

2.229.763.744

Reinpadstraat 10 box 2

3600 Genk

Active since 30 September 1995

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

FC HERENSTRAAT

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0453.929.910
VAT number: BE 0453.929.910
Registered office: Peerboomstraat 23, 3600 Genk
Names & denominations: Dr. INDESTEEGE -DR.HORVATH
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 November 1994
Peppol: Active · Active since 23 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗